These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31977)

  • 21. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of interleukin-12 in cancer immunotherapy].
    Mazzolini G; Melero I; Prieto J
    Medicina (B Aires); 2004; 64(1):77-8. PubMed ID: 15034963
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanotechnology and cancer nanomedicine.
    Liang XJ
    Biotechnol Adv; 2014; 32(4):665. PubMed ID: 24913056
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological response modifiers in regional cancer therapy.
    Bergh JC
    Eur J Surg Suppl; 1991 May; (561):87-90. PubMed ID: 1720055
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings of the NCI-EORTC symposium on new drugs in cancer therapy, Institut Jules Bordet, September 7--8, 1978 Brussels, Belgium.
    Cancer Treat Rep; 1979 May; 63(5):807-936. PubMed ID: 36983
    [No Abstract]   [Full Text] [Related]  

  • 26. AIDS meeting. Edict limits U.S. speakers at Bangkok conference.
    Couzin J
    Science; 2004 Apr; 304(5670):499-500. PubMed ID: 15105465
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proceedings of the Second Annual Conference on the Status of Predictive Tools in Application to Safety Evaluation: Hazards from Toxic Chemicals.
    J Environ Pathol Toxicol; 1978; 2(1):1-223. PubMed ID: 31408
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: the Applications of Bioinformatics in Cancer Detection Workshop.
    Kapetanovic IM; Umar A; Khan J
    Ann N Y Acad Sci; 2004 May; 1020():1-9. PubMed ID: 15208178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus conference on screening for lung cancer.
    Fink DJ; Upton AC
    Vet Hum Toxicol; 1979 Jun; 21(3):227-8. PubMed ID: 37635
    [No Abstract]   [Full Text] [Related]  

  • 31. Bridging the gap between research and practice.
    Braillon A
    Am J Med; 2011 Nov; 124(11):e15. PubMed ID: 21684514
    [No Abstract]   [Full Text] [Related]  

  • 32. National Cancer Institute initiative for development of novel imaging technologies.
    Clarke LP; Croft BY; Menkens A; Torres-Anjel MJ; Hoffman JM; Sullivan DC
    Acad Radiol; 2000 Jun; 7(6):481-3. PubMed ID: 10845407
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of imaging in clinical trials of antiangiogenesis therapy in oncology.
    Tatum JL; Hoffman JM
    Acad Radiol; 2000 Oct; 7(10):798-9. PubMed ID: 11048877
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccine adjuvants as potential cancer immunotherapeutics.
    Temizoz B; Kuroda E; Ishii KJ
    Int Immunol; 2016 Jul; 28(7):329-38. PubMed ID: 27006304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National Cancer Institute support for scientific conferences.
    Kalberer JT; Morrison BH
    Cancer Res; 1980 Jul; 40(7):2617-22. PubMed ID: 6893013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cancer immunotherapy].
    Hurtado Ruano T
    Rev Esp Oncol; 1984; 31(2):359-69. PubMed ID: 6545712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sterile' inflammation and autophagy in cancer immunotherapy.
    Harada M; Harashima N
    Immunotherapy; 2010 Sep; 2(5):599-601. PubMed ID: 20874641
    [No Abstract]   [Full Text] [Related]  

  • 38. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy.
    Dredge K; Marriott JB; Todryk SM; Dalgleish AG
    Cancer Immunol Immunother; 2002 Nov; 51(10):521-31. PubMed ID: 12384803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy in anticancer responses.
    Whelan M
    Curr Opin Mol Ther; 2004 Feb; 6(1):8-9. PubMed ID: 15011775
    [No Abstract]   [Full Text] [Related]  

  • 40. Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.
    Malyguine A; Umansky V; Kotlan B; Aptsiauri N; Shurin MR
    J Immunotoxicol; 2012; 9(3):231-5. PubMed ID: 22639903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.